Novo and Lilly launched their obesity drugs in India last year. The market is forecast to reach ₹80 billion ($851.79 million) ...

Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for ...

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ...

One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO) cut prices on Wegovy and Ozempic by up to 48% in India ...

Sudden availability of so many cheap versions has raised concerns among health care professionals about malpractice and ...

Many people who take GLP-1 medications pay for them completely out of pocket—including about a quarter of people with health ...

It has been nearly two weeks since the semaglutide patent expired, and India’s weight-loss drug market is already opening up ...

The Trump administration has secured pricing agreements with major drugmakers to lower GLP-1 weight loss drug costs to ...

With wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include ...